ReviewJournal of inflammation research2022

The NLRP3 Inflammasome as a Novel Therapeutic Target for Cardiac Fibrosis.

Jiwen Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.